AI plus ultrasound could catch heart and lung decline before it turns critical
NCT ID NCT07814118
First seen Sep 10, 2026 · Last updated Sep 11, 2026 · Updated 1 time
Summary
Researchers are testing whether artificial intelligence can combine ultrasound images with routine health data to track changes in a person's physiology over time. The study enrolls adults with heart, lung, kidney, or blood vessel conditions, as well as healthy volunteers. The goal is to see if AI can detect early signs of worsening health, such as decompensation, earlier than standard single-time-point assessments.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- multimodal ultrasound imaging combined with artificial intelligence
- What this could lead to
- If it works, doctors could spot worsening heart, lung, and blood vessel conditions earlier, possibly before symptoms become severe. That could mean faster treatment and fewer emergency hospital visits.
- What could go wrong
- This is an observational study, so it cannot prove that early detection saves lives. The AI models may not work well across different patients, and the study may not capture enough data to reliably predict rare events.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 25,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2026
- Expected to finish
-
Sep 2046
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
OMNIPHYS will enroll a diverse adult population including healthy volunteers and participants receiving routine clinical evaluation or care. The study will include individuals across cardiovascular, vascular, pulmonary, renal, and systemic physiologic conditions, with disease-specific and physiologic subcohorts analyzed within a common longitudinal framework. Multimodal ultrasound, Doppler, physiologic measurements, clinical data, laboratory data, and longitudinal outcomes will be evaluated to characterize individual physiologic states, trajectories, transitions, treatment responses, and recovery patterns.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Adults aged 18 years or older who are capable of providing informed consent, or who meet applicable legally authorized representative requirements where permitted. 2. Individuals undergoing routine clinical evaluation, diagnostic imaging, monitoring, treatment, or longitudinal follow-up, including individuals with relevant cardiovascular, vascular, pulmonary, renal, systemic, or other conditions represented within the OMNIPHYS research framework. 3. Healthy volunteers without the conditions under study may participate as reference participants. 4. Ability to undergo at least one protocol-relevant physiologic or imaging assessment and/or contribute eligible routinely collected clinical data. 5. Availability of sufficient clinical, physiologic, imaging, or longitudinal outcome data for the applicable analysis. 6. Willingness to permit collection and longitudinal analysis of protocol-defined research data in accordance with informed consent and applicable privacy and data-governance requirements. Exclusion Criteria: 1. Inability or unwillingness to provide informed consent or otherwise meet applicable consent requirements. 2. Inability to obtain interpretable protocol-relevant physiologic or imaging data when such data are required for the applicable analysis. 3. Conditions or circumstances that, in the judgment of the responsible clinical investigator, make participation inappropriate or prevent meaningful longitudinal follow-up. 4. Withdrawal of consent or request for discontinuation of research participation where applicable. 5. Any circumstance that would prevent collection, secure handling, or analysis of study data in accordance with the approved protocol and applicable requirements.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute kidney injury are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Truway Health, Inc.
New York, New York, 10016, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can toe exercises straighten young bunions?
- Can donated immune cells calm the cytokine storm?
- Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin
- Steroid dose showdown: can more dexamethasone save lives in respiratory failure?
- Can pressing six points on the body help older adults sleep?
- Common Anti-Nausea drugs under scrutiny for kidney risk during chemo